a year ago
GILD
AnalystsAsthika GoonewardeneAsthika Goonewardene's Stock Forecasts
AnalystsAsthika Goonewardene
Sectors:
Industries:
Analyst Ranking
Top 28%
#1544 out of 5510 analysts
Average Return
+2.22%
Win Rate
45%46 out of 102
Risk vs Reward
Poor
Good
Asthika Goonewardene's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +418.57% | $40.50 | $210.02 | 2025-09-05 - 2026-09-04 | Strong Buy |
Mersana Therapeutics IncMRSN | +222.63% | $8.50 | $27.43 | 2025-05-16 - 2025-11-13 | Strong Buy |
Immunogen IncIMGN | +180.83% | $5.32 | $14.94 | 2022-11-21 - 2023-11-20 | Strong Buy |
Forty Seven IncFTSV | +163.68% | $35.74 | $94.24 | 2020-01-13 - 2020-03-03 | Strong Buy |
Allogene Therapeutics IncALLO | +144.49% | $0.95 | $2.33 | 2025-05-14 - 2026-05-13 | Strong Buy |
Asthika Goonewardene Analyst Color
Get additional color on Asthika Goonewardene's coverage of popular stocks
3 years ago
IOVA
3 years ago
ACLX
Asthika Goonewardene's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcellx IncACLX | 6 | Hold | $120.00 | +4.28% | Downgrades | 7 months ago |
Zymeworks IncZYME | 1 | Strong Buy | $40.00 | +48.98% | Initiates Coverage On | 9 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $43.00 | +50.51% | Initiates Coverage On | 10 months ago |
Mersana Therapeutics IncMRSN | 5 | Hold | $30.75 | +5.74% | Downgrades | 10 months ago |
Genmab AGMAB | 14 | Strong Buy | $48.00 | +47.01% | Reiterates | 10 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $145.00 | -0.96% | Reiterates | 10 months ago |
Arcus Biosciences IncRCUS | 2 | Strong Buy | $39.00 | +62.03% | Reiterates | a year ago |
Merus NvMRUS | 3 | Hold | $97.00 | +7.78% | Downgrades | a year ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | a year ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $99.00 | N/A | Initiates Coverage On | a year ago |
Exelixis IncEXEL | 10 | Strong Buy | $49.00 | N/A | Maintains | a year ago |
Igm Biosciences IncIGMS | 9 | Hold | $1.00 | N/A | Maintains | a year ago |
Biontech SeBNTX | 3 | Strong Buy | $155.00 | N/A | Reiterates | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Allogene Therapeutics IncALLO | 6 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Autolus Therapeutics PLCAUTL | 4 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Iovance Biotherapeutics IncIOVA | 6 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $7.00 | N/A | Downgrades | 2 years ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Sutro Biopharma IncSTRO | 6 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Compugen LtdCGEN | 5 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Caribou Biosciences IncCRBU | 3 | Strong Buy | $19.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 3 | Hold | $229.00 | N/A | Reiterates | 3 years ago |
Hookipa Pharma IncHOOK | 4 | Strong Buy | $40.00 | N/A | Reiterates | 3 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $432.00 | N/A | Reiterates | 3 years ago |
Immunogen IncIMGN | 2 | Strong Buy | $18.00 | N/A | Maintains | 3 years ago |
Instil Bio IncTIL | 1 | Hold | $120.00 | N/A | Reinstates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $3.00 | N/A | Downgrades | 4 years ago |
Harpoon Therapeutics IncHARP | 3 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Celularity IncCELU | 3 | Hold | $60.00 | N/A | Maintains | 4 years ago |
Nextcure IncNXTC | 4 | Strong Buy | $180.00 | N/A | Maintains | 4 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.